Market Research Reports and Industry Reports

KPI Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION
Summary

KPI Therapeutics Inc (KPI), formerly Kineta Prime Inc. is a biotechnology company that develops therapies for autoimmunity and chronic pain. The companys pipeline products comprise Dalazatide, a synthetic peptide for the treatment of autoimmune disorders; KPI-190, an eye drop developed for several eye diseases such as uveitis, dry eye syndrome; and KPI-150, a topical cream for atopic dermatitis, psoriasis, and other dermatological complications associated with inflammatory diseases. KPI also develops chronic pain platform products which include Conopeptide, a amino acid peptide conotoxin being developed for traumatic injury pain, neuropathic pain indications and burn pain. KPI is headquartered in Seattle, Washington, the US.

KPI Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
KPI Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
KPI Therapeutics Raises Funds through Venture Financing 10
KPI Therapeutics Raises USD0.5 Million in Venture Financing 11
KPI Therapeutics Raises USD0.03 Million in Venture Financing 12
KPI Therapeutics Raises USD1.6 Million in Venture Financing 13
Partnerships 14
Kineta, KPI Therapeutics Enter into Partnership with UW Medicine and University of Washington 14
KPI Therapeutics Inc - Key Competitors 15
KPI Therapeutics Inc - Key Employees 16
KPI Therapeutics Inc - Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Product News 18
06/20/2016: Dalazatide as a Potential Immunotherapy for Lupus to be Presented at Immunology Conference 18
06/10/2016: Alliance for Children Therapeutics Presents Dalazatide Data Demonstrating Positive Response in Lupus 19
05/23/2016: KPI Therapeutics to Present Updated Dalazatide Study Data in Lupus 20
05/11/2016: KPI Therapeutics Non-Opiate Pain Drug Effective in Neuropathic Pain and Burn Pain 21
02/08/2016: KPI Therapeutics Initiates Research Program In Eye Diseases 22
02/08/2016: KPI Therapeutics Initiates Research Program In Skin Diseases 23
Clinical Trials 24
May 12, 2016: KPI Therapeutics Presents Dalazatide Plaque Psoriasis Data at Dermatology Conference 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List Of Tables


KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
KPI Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
KPI Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
KPI Therapeutics Raises Funds through Venture Financing 10
KPI Therapeutics Raises USD0.5 Million in Venture Financing 11
KPI Therapeutics Raises USD0.03 Million in Venture Financing 12
KPI Therapeutics Raises USD1.6 Million in Venture Financing 13
Kineta, KPI Therapeutics Enter into Partnership with UW Medicine and University of Washington 14
KPI Therapeutics Inc, Key Competitors 15
KPI Therapeutics Inc, Key Employees 16

List Of Figures


KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
KPI Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Asia-Pacific Automotive Cockpit Electronics Market Report 2017

In this report, the Asia-Pacific Automotive Cockpit Electronics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022,

USD 4000View Report

KPI Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

KPI Therapeutics Inc (KPI), formerly Kineta Prime Inc. is a biotechnology company that develops therapies for autoimmunity and chronic pain. The companys pipeline products comprise Dalazatide, a synthetic peptide for

USD 250View Report

AP I/GVKPIL – New Yogyakarta International Airport – Indonesia Project Profile

Synopsis AP I/GVKPIL New Yogyakarta International Airport Indonesia Project Profile contains information on the scope of the project including project overview and location. The profile also details project ownership

USD 75View Report

Respira Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Respira Therapeutics Inc (Respira) is a provider of dry powder inhaler technologies. The company develops robust portfolio of inhaled drug products for orphan pulmonary diseases. Its products under development are

USD 250View Report

Blackthorn Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Blackthorn Therapeutics Inc (Blackthorn Therapeutics) is a clinical-stage biopharmaceutical company which discovers and develops novel targeted treatments for neurobehavioral disorders. The company is building pipeline of small molecule modulates which

USD 250View Report

Viracta Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Viracta Therapeutics Inc (Viracta) is a drug development company which focuses on the development of proprietary viral activation therapy platform to address cancers associated with the Epstein-Barr Virus (EBV) and

USD 250View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
Country Code.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Aug 2017
No. of Pages :25
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube
paykasa bozdurma,paykasa bozdurma,astropay bozdurma,paykasa,paykasa,paykasa bozdurma,paykasa,astropay bozdurma,justin kart,bitcoin bozdurma,paykasa bozum,paykasa kart bozdurma,
beylikduzu escort,bahçeşehir escort,escort istanbul,istanbul escort,sex hikayeleri,pendik escort,
pedalebiellese.com,
istanbul escort bayan,besiktas escort,maltepe escort,kadikoy escort bayan,tekirdag escort bayan,findikzade escort,antalya escort bayan,ankara escort bayan,
Böcek İlaçlama,şehirler arası nakliyat,şehirler arası evden eve nakliyat,ofis taşıma,gebze evden eve nakliyat,kadıköy evden eve nakliyat,istanbul evden eve nakliyat,epoksi zemin,
ankara escort,ankara escort,ankara escort,
tipobet,
seo teknikleri wordpress ücretsiz tema istanbul sexs shop hacklink e sigara sexs shop